Getting the correct treatment for bronchiectasis, a chronic lung condition affecting 350,000 to 500,000 adults nationwide, is necessary to slow disease progression and help prevent further damage to ...
A chronic cough can be due to many things from asthma to post-COVID-19. Here's how to figure out why you can't stop coughing ...
ERS issues new bronchiectasis guidelines to improve patient care, standardise treatment, and reduce variability in global ...
Highly symptomatic bronchiectasis patients have increased exacerbation risks, regardless of previous exacerbation history or disease severity. Current guidelines do not recommend preventive treatments ...
August 22, 2012 — A new application of a drug that was approved in 1996 and has been widely used since significantly decreased the frequency of exacerbations and increased the time to first ...
BRIDGEWATER, N.J., Aug. 12, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform ...
Doreen Addrizzo-Harris, MD, FCCP discusses Brinsupri ™ (brensocatib), a new FDA-approved treatment for non-cystic fibrosis bronchiectasis. Dr Addrizzo-Harris is the Fiona and Stanley Druckenmiller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback